Brussels, 11/07/2014 (Agence Europe) - Fifteen European countries have come together “for the first time”, on the initiative of France, to negotiate a reduction in the price of a new hepatitis C drug, Sovaldi, French Minister for Health Marisol Touraine announced on Thursday 10 July. Sovaldi, developed by the American laboratory Gilead, is a new hepatitis C treatment, but its stratospheric cost (more than €50,000 for a 12-week course) has alarmed the health authorities, which have...